Data / Drug companies / Raritan Pharmaceuticals Inc

Raritan Pharmaceuticals Inc: 47 products in the FDA NDC directory, labeler code 68163

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Raritan Pharmaceuticals Inc (labeler code 68163) lists 47 products in the FDA National Drug Code Directory, covering 26 finished drugs by generic name. By type: 47 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on August 14, 2026.

The request: Watch Raritan Pharmaceuticals Inc (FDA labeler code 68163): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code

68163

Products in commercial distribution

47

Packages

51

Finished drugs by generic name

26

Prescription products

0

Over the counter products

47

Flagged as original packager

37 of 37 products that carry the flag

Started marketing in the last 12 months

4

Earliest marketing start

December 17, 2018

openFDA record search

api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Products by type

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.